Studies in hepatocellular carcinoma (64, 65) and acute myeloid leukemia (AML) (66) suggest that LIPT1 expression is elevated and associated with poor prognosis, whereas another study in lung cancer found the opposite (67). Here, LIPT1 is linked to lung cancer.